Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes  Diana Mina, Kirsten L. Johansen, Charles E. McCulloch, Michael A. Steinman, Barbara A. Grimes, Julie H. Ishida  American Journal of Kidney Diseases  Volume 73, Issue 4, Pages 525-532 (April 2019) DOI: 10.1053/j.ajkd.2018.11.008 Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Cohort selection. ∗Patients were additionally excluded if any of the following events occurred in January 2011: death, kidney transplantation, change in modality away from in-center hemodialysis, uncertain/recovered kidney function, loss to follow-up, withdrawal from dialysis therapy, or loss of Part D coverage, which precluded our ability to ascertain exposure status as of February 2011. Abbreviations: BMI, body mass index; VA, Veterans Affairs. American Journal of Kidney Diseases 2019 73, 525-532DOI: (10.1053/j.ajkd.2018.11.008) Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions